Medical Research Council of Canada Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Ottawa Canada (2000)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

fluticasone (cutivate) (1 trial)

Drugs in Phase 3 Trials (2)

indomethacin (indocin) (1 trial)

nitric oxide (inomax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Birth Weight (Phase 3)

Ductus Arteriosus, Patent (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Persistent Fetal Circulation Syndrome (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Aspiration (Phase 3)

Pulmonary Valve Insufficiency (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Insufficiency (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3